Insights from BCC Research

Traditional Methods of Alzheimer Disease Diagnosis
Diagnosing Alzheimer Disease (AD) typically involves the use of a combination of neuropsychological tests and neuroimaging assessments. A widely used cognitive test is the Mini-Mental State Examination (MMSE), which evaluates orientation, attention, memory, language and visual-spatial skills.

Biotechnology research is advancing in many fields. For example, genetic sequencing technology is advancing rapidly, with a heaving focus in cancer diagnostics within the healthcare sector.

As the life sciences field evolves, so do the job opportunities it offers.

Biomarkers are at the core of identifying any disease or biological condition, and the discovery of new biomarkers has enormous commercial potential. While aiding in diagnostics, prognostics and companion diagnostics, biomarkers are becoming essential tools in one critical process: drug development. As a result, the biomarkers market has been rapidly expanding in recent years, according to a recent webinar led by BCC Research analyst Marianna Tcherpakov, PhD.